P
aget's disease of nipple is a rare form of breast cancer; it is only 1-3% of all breast cancer.
1 It arises from small tubular ducts at the nipple. The nipple becomes a dark red color, itchy and irritated. According to the National Cancer Institute, more than 97% of cases have cancer either DCIS or IDC, 2 somewhere else in the breast. The unusual changes in the nipple are often the fi rst indication of Paget's disease. The development of Paget's disease is unknown. There are two theories that can explain its origin:
1. Tumor arises from small tubular ducts in the breast and spreads to the nipple 2. Nipple becames cancerous itself and a second breast cancer appears to be completely separate from the Paget's disease.
It is commonly found in women older than 50 years old. A man contracting the disease is rare and usually develops after the age of 70 years. Usually it occurs unilaterally. The immunohistochemical study usually is over expression of the c-erb-B2 oncogene.
Investigation
• Digital mammography either normal or mass, nipple may retract calcifi cation or subareolar mass.
• Ultrasonic scan found heterogenic mass/masses.
• MRI demonstrated contrast enhanced mass or masses.
• CESM is helpful, the sensitivity and specifi city is equal to an MRI study 3 but CESM is less expensive.
Treatment
Wide excision, lumbectomy, mastectomy and sentinel node biopsy, breast conservative therapy with complete resection of nipple and areolar complex and local radiation therapy which may be used in cases of less extensive disease. For extensive disease, stage 3-4 hormonal, targeted therapy or chemotherapy may be used depending on hormonal tests and IHC for oncogenes.
Case Report
A 46-year-old woman developed a dark red spot at the leftnipple for 5 months (Figure 1) . No other symptom is noted. No palpable breast mass is detected. All other fi ndings and all laboratory fi ndings are unremarkable, ultrasonic scan of the breasts reveal hypoechogenic lesions in both breasts. They appear stable for 2 years, suggestive of benign lesions (BIRADS 3), biopsy at left nipple reveals Paget's disease (Figure 2 ).
Imaging studies between MRI Breast vs Contrast Enhanced Spectral Mammography (CESM)

MRI Breast with dynamic study was performed and all techniques, clinical application and interpretation are well described. 1
The fi ndings of MRI Breast with contrast enhanced study revealed two lesions at the medial aspect of the left breast with rapid contrast enhancement on the arterial phase and then declined to gradually washout on delayed phase ( Figure 3 -4) . No contrast enhancement at sentinel node was observed.
Contrast Enhanced Spectral Mammography (CESM)
The radiologist was requested by the surgeon to localize this case with Paget's disease at the left nipple who from the previous ultrasonic scan showed multiple hypoechogenic masses in both breasts which appear unchanged for 2 years. How to localize these two lesions of the left breast and other lesions which are not identifi ed by contrast enhancement. To avoid a repeat MRI Breast with contrast enhancement and given the diffi culty in placing markers on the skin, the practical way to approach this case for localization is as follows:
• First step: Markers on the skin of both breasts by using small fi sh oil pill on the skin by ultrasonic scan. • Second step: MRI breast without contrast enhancement by using T1W, T2W, and short-tauinversion recovery (STIR). The previous study MRI breast with dynamic gadolinium (Gd) was preformed already, and so we prefer to reduce the cost of a repeat Gd enhancement MRI study. • Third step: CESM with markers in place ( Figure 5 ).
Two masses with contrast enhancement are seen near the marker on the left breast (see arrows). In addition, there is another small contrast enhancement at the sentinel node which is not demonstrated by MRI Breast with Gd study (see arrow). No contrast enhanced mass on the right breast was observed.
CESM was preformed, the detail of technique as well as indications have been described.
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Discussion
This is a presentation of Paget's disease of the left nipple which is a rare condition. For this case with follow-up multiple masses at both breasts which appear stable for 2 years, subsequently the patient developed Paget's disease at the left nipple. The planning of investigation for staging and treatment is the most important issue to address. Theoretically, Paget's disease may be cancer in the left breast as either single or multiple foci and possible in contralateral, although this is even less possible. The second question is which one (or more) of the lesions are cancer. And the third question is how to localize the lesion/s. We suggest the modalities and sequences by ultrasonic scan with markers on the skin and using limitation MRI T1W, T2W, and STIR. and CESM for localized confi rmation. As a previous MR Breast with Gd study has already been performed in this case we consider a way to reduce the cost of repeated MR with contrast enhancement. In comparison the fi ndings of MRI and CESM for breast localization are similar. However in this case, CESM could demonstrate positive sentinel node and even microscopic metastasis ( Figure 6C ). But MRI Breast with contrast enhancement could not detect this. This is maybe possible for other indications of CESM in the detection of sentinel nodes as a surgical requirement for the adjustment in the planning of an operation.
Conclusion
A case presentation of Paget's disease of nipple with multiple hypoechogenic masses at both breasts. The planning for localization to identify the suspected malignancy lesion by using ultrasonic scan with fi sh oil markers on the skin is performed initially and followed by a limited MRI study. CESM is performed for confi rmation. The fi ndings for breast localization using either MRI or CESM are similar. Hence, we prefer CESM than MRI study for breast localization because CESM is relatively inexpensive, less time is needed for examination and it is far more convenient for the patient. In addition, for this case, CESM could detect positive sentinel node which is not detected by MRI of the breast. It may help in staging and may help the surgeon for treatment planning. 
Questions
